background
increas
debat
surround
mask
respir
intervent
control
respiratori
infect
transmiss
healthcar
commun
set
decis
maker
consid
recommend
evalu
provid
effici
protect
strategi
minimum
cost
aim
review
identifi
evalu
exist
econom
evalu
literatur
area
offer
advic
futur
evalu
topic
conduct
method
search
scopu
databas
literatur
econom
evalu
mask
respir
use
control
respiratori
infect
transmiss
refer
list
identifi
studi
also
manual
search
seven
studi
met
inclus
criteria
initi
studi
identifi
search
strategi
manual
search
result
five
studi
consid
intervent
season
andor
pandem
influenza
one
also
consid
sar
sever
acut
respiratori
syndrom
two
studi
focuss
tuberculosi
transmiss
control
intervent
set
methodolog
studi
vari
greatli
lowmiddl
incom
set
identifi
one
review
studi
cite
clinic
evid
inform
maskrespir
intervent
effect
paramet
mask
respir
intervent
gener
report
studi
author
cost
save
costeffect
compar
intervent
control
measur
howev
evalu
import
limit
conclus
given
larg
cost
differenti
mask
respir
need
comprehens
econom
evalu
compar
rel
cost
benefit
intervent
situat
set
altern
option
potenti
applic
present
insuffici
well
conduct
costeffect
studi
inform
decisionmak
valu
money
altern
maskrespir
option
world
health
organis
centr
diseas
control
cdc
guidelin
recommend
use
mask
lowrisk
set
respir
highrisk
set
eg
aerosol
gener
procedur
protect
healthcar
worker
hcw
season
influenza
use
respir
time
also
advis
hcw
care
patient
suspect
infecti
tuberculosi
measur
import
protect
hcw
well
reduc
spread
respiratori
infect
within
hospit
help
reduc
cost
associ
hcw
absente
cost
nosocomi
infect
maskrespir
avail
may
also
prove
crucial
context
newli
emerg
respiratori
infect
particularli
diseas
sar
sever
acut
respiratori
syndrom
merscov
middl
east
respiratori
syndrom
coronaviru
may
initi
vaccin
treatment
avail
leav
nonpharmaceut
measur
avail
protect
hcw
diseas
pandem
influenza
relianc
vaccin
protect
alway
possibl
due
time
delay
vaccin
develop
manufactur
distribut
furthermor
stockpil
rel
expens
antivir
influenza
pandem
may
costeffect
low
middl
incom
set
absenc
standardis
maskrespir
nomenclatur
use
term
mask
indic
standard
surgic
mask
also
refer
medic
mask
countri
special
engin
protect
wearer
aerosol
transmiss
droplet
nuclei
viral
particl
respir
use
denot
person
protect
facemask
engin
filtrat
fit
prevent
transmiss
respiratori
virus
aerosol
droplet
sever
air
purifi
respir
filter
inhal
air
filter
materi
avail
use
hcw
includ
hepa
higheffici
particul
air
parp
power
air
purifi
respir
dm
dustmist
dmf
dustmistfum
substanti
differ
cost
differ
maskrespir
option
cost
differ
may
import
determin
develop
countri
specif
maskrespir
guidelin
hcw
exampl
costli
parp
recommend
guidelin
high
incom
countri
mani
countri
guidelin
recommend
fit
test
train
session
respir
use
contain
limit
descript
entail
fit
test
qualit
quantit
latter
expens
ad
substanti
cost
respir
use
mask
use
requir
fit
test
two
studi
evalu
maskrespir
use
includ
previou
econom
review
influenza
pandem
measur
small
grow
number
econom
evalu
masksrespir
aim
review
identifi
evalu
exist
literatur
offer
advic
futur
evalu
topic
conduct
scopu
databas
search
englishlanguag
literatur
econom
evalu
mask
respir
use
control
respiratori
infect
transmiss
scopu
includ
coverag
medlin
embas
major
relev
literatur
identifi
initi
scopu
search
includ
influenza
tuberculosi
either
singl
focu
one
diseas
control
reason
term
influenza
tuberculosi
use
addit
gener
term
relat
infect
transmiss
ie
prevent
identif
articl
focus
infecti
respiratori
diseas
final
search
strategi
contain
public
august
use
search
term
keyword
titl
abstract
facemask
mask
respir
non
pharm
person
protect
econom
cost
infect
transmi
influenza
tuberculosi
result
initi
scopu
search
screen
fig
abstract
articl
review
basi
whether
econom
evalu
eg
costeffect
costutil
costbenefit
studi
whether
intervent
evalu
involv
mask
andor
respir
strategi
prevent
transmiss
respiratori
infect
process
full
text
articl
consid
potenti
relev
full
text
review
elig
six
confirm
econom
evalu
mask
respir
infect
control
intervent
one
addit
studi
dan
et
al
identifi
refer
list
systemat
review
main
studi
use
qualit
synthesi
four
cost
studi
publish
examin
cost
intervent
classifi
full
econom
evalu
ie
examin
health
impact
cost
save
prevent
ill
data
includ
studi
independ
extract
intro
spread
sheet
sm
review
atn
disagr
resolv
discuss
author
seven
econom
evalu
maskrespir
use
control
respiratori
infect
identifi
tabl
studi
vari
wide
set
methodolog
studi
adal
et
al
nettleman
et
al
publish
tuberculosi
healthcar
set
five
other
publish
post
focus
season
pandem
influenza
one
dan
et
al
also
consid
sar
scenario
studi
date
maskrespir
econom
evalu
identifi
focu
sar
merscov
respiratori
virus
influenza
also
econom
evalu
studi
identifi
mask
respir
use
prevent
transmiss
ebola
intervent
evalu
studi
includ
respir
hepa
dm
dmf
respir
surgic
mask
amongst
studi
focus
influenza
two
five
dan
et
al
chen
liao
integr
maskrespir
use
scenario
conjunct
nonpharmaceut
control
measur
eg
natur
ventil
isol
measur
oppos
evalu
use
masksrespir
exclus
make
difficult
assess
degre
maskrespir
aspect
intervent
drive
costeffect
result
attribut
control
measur
includ
set
evalu
studi
vari
broadli
influenza
studi
tuberculosi
three
five
influenza
studi
commun
set
other
one
consid
control
measur
commun
hospit
set
last
set
primari
school
seven
identifi
studi
set
usa
develop
countri
limit
generalis
find
eg
decis
make
low
resourc
set
lack
studi
low
resourc
set
cite
one
major
impedi
use
costeffect
analysi
pandem
influenza
prepared
plan
context
four
five
influenza
studi
includ
number
infect
case
one
outcom
measur
intervent
effect
tabl
remain
influenza
studi
quantifi
report
consequ
infect
outcom
eg
prevent
death
hospitalis
outpati
visit
absente
tuberculosi
studi
measur
convers
rate
newli
posit
protein
deriv
test
hcw
studi
hospit
posit
test
indic
chanc
individu
develop
activ
tuberculosi
lifetim
one
two
studi
also
estim
number
patient
isol
known
tuberculosi
per
month
confirm
pulmonari
tuberculosi
case
patient
past
year
activ
case
pulmonari
tuberculosi
hcw
last
year
addit
inform
provid
complet
measur
impact
intervent
three
seven
studi
report
result
cost
per
unit
effect
evalu
dan
et
al
influenza
sar
report
increment
cost
per
death
avert
two
tuberculosi
studi
one
report
cost
prevent
singl
occup
case
tuberculosi
next
year
report
cost
per
tuberculosi
case
prevent
cost
per
life
save
two
pandem
influenza
studi
evalu
combin
intervent
commun
conclud
maskrespir
intervent
cost
save
pandem
set
first
estim
substanti
net
save
popul
worn
respir
influenza
assum
effect
second
estim
surgic
mask
use
complianc
would
yield
save
million
far
exceed
estim
intervent
cost
million
influenza
model
studi
jone
adida
focus
demonstr
feasibl
method
rather
report
key
econom
result
influenza
studi
chen
liao
calcul
cost
per
individu
implement
control
measur
limit
inclus
cost
intervent
outpati
treatment
cost
approach
incorpor
intervent
effect
amongst
seven
studi
vari
tabl
tuberculosi
evalu
adal
et
al
nettleman
et
al
report
efficaci
studi
avail
thu
specif
measur
mask
respir
effect
includ
evalu
nettleman
et
al
assum
best
case
scenario
hepa
respir
would
prevent
hcw
exposur
tuberculosi
data
cite
support
estim
adal
et
al
implicitli
assum
hcw
case
tuberculosi
may
acquir
patient
isol
activ
tuberculosi
would
prevent
intervent
five
influenza
studi
tracht
et
al
studi
attempt
utilis
clinic
efficaci
data
obtain
randomis
trial
univers
resid
set
found
signific
decreas
influenzalik
ill
hand
hygien
medic
mask
use
togeth
compar
control
differ
medic
mask
use
alon
tracht
et
al
use
result
estim
respir
use
provid
decreas
suscept
influenza
may
robust
clinic
trial
measur
differ
outcom
ie
influenzalik
ill
influenza
case
assum
differ
efficaci
medic
mask
respir
base
find
loeb
et
al
although
trial
found
evid
differ
studi
jone
adida
deriv
efficaci
estim
assign
protect
factor
apf
measur
respir
releas
nation
institut
occup
safeti
health
apf
estim
laboratori
test
complet
organis
includ
laboratori
test
quantit
measur
fit
respir
fit
test
ensur
protect
seal
around
wearer
face
cahil
et
al
also
use
efficaci
estim
laboratori
investig
data
estim
may
limit
applic
measur
realworld
effect
dan
et
al
estim
baselin
intervent
effect
rate
protect
equip
includ
mask
isol
precaut
increas
cite
data
support
estim
howev
failur
rate
transmiss
still
occur
despit
use
protect
equip
isol
measur
obtain
hospit
simul
studi
chen
liao
appli
rel
efficaci
estim
mask
combin
control
measur
develop
previou
model
studi
cite
support
data
efficaci
input
assumpt
tracht
et
al
none
analys
use
intervent
effect
estim
clinic
trial
maskrespir
randomis
trial
publish
date
intervent
commun
healthcar
set
two
seven
evalu
dan
et
al
jone
adida
et
al
explicitli
state
econom
perspect
conduct
evalu
polici
develop
view
healthcar
institut
perspect
basi
cost
includ
exclud
four
seven
studi
align
healthcar
payer
perspect
remain
three
societ
perspect
eg
includ
form
product
cost
tuberculosi
evalu
adal
et
al
nettleman
et
al
consid
cost
healthcar
provid
perspect
reflect
object
prevent
burden
nosocomi
case
hcw
patient
influenza
studi
frequent
appli
societ
perspect
consist
substanti
econom
impact
product
loss
due
influenza
absente
report
cost
includ
evalu
often
transpar
one
evalu
dan
et
al
identifi
omiss
indirect
cost
lost
revenu
cancel
elect
surgeri
decreas
outpati
attend
lost
clinic
teach
time
administr
cost
senior
staff
meet
cost
discuss
influenza
model
studi
may
relev
tuberculosi
studi
adal
et
al
nettleman
et
al
reli
hospit
databas
number
masksrespir
use
multipli
unit
cost
calcul
total
cost
administr
cost
thoroughli
report
tuberculosi
studi
adal
et
al
includ
staff
program
plan
time
staff
medic
evalu
time
studi
estim
cost
per
case
includ
cost
infect
individu
exampl
one
influenza
model
studi
jone
adida
assum
fix
averag
cost
infect
may
alway
ideal
method
cost
resourc
use
cost
averag
case
may
vari
amongst
patient
tracht
et
al
alloc
separ
averag
hospit
cost
per
day
due
influenza
infect
three
age
group
three
studi
evalu
intervent
commun
includ
impact
complianc
includ
simpl
approach
use
cahil
et
al
assess
adher
scenario
well
jone
adida
estim
complianc
assum
tracht
et
al
conduct
thorough
sensit
analysi
divid
popul
three
age
group
test
three
scenario
differ
proport
complianc
group
studi
attempt
use
complianc
rate
realworld
investig
clinic
trial
rel
small
number
econom
evalu
maskrespir
use
met
inclus
criteria
exist
studi
found
address
costeffect
intervent
lowmiddl
incom
countri
seven
evalu
identifi
limit
util
advis
decis
maker
valu
money
mask
respir
offer
compar
health
spend
choic
due
report
result
form
intermedi
outcom
eg
case
prevent
analysi
combin
mask
respir
protect
measur
evalu
also
limit
inclus
clinic
data
inform
effect
estim
impact
intervent
complianc
identifi
studi
complianc
major
implic
maskrespir
intervent
target
hcw
exampl
obtain
high
adher
hcw
feasibl
highincom
countri
australia
variat
hcw
maskrespir
complianc
observ
countri
lower
rate
seen
uk
hospit
compar
hong
kong
singapor
influenza
maskrespir
adher
primarili
driven
perceiv
suscept
infecti
diseas
threat
present
clinic
evid
compar
mask
respir
effect
one
review
studi
cite
clinic
evid
support
maskrespir
intervent
effect
paramet
howev
grow
bodi
research
area
initi
systemat
review
topic
report
pool
efficaci
measur
case
control
studi
respir
medic
mask
respect
prevent
respiratori
virus
weak
initi
review
case
control
studi
includ
metaanalysi
focus
exclus
sar
consequ
assum
conclus
metaanalysi
necessarili
true
influenza
respiratori
infect
updat
edit
review
conclud
evid
signific
differ
effect
respir
medic
mask
howev
conclus
heavili
influenc
singl
cluster
randomis
trial
loeb
et
al
compar
respir
medic
mask
use
select
highrisk
situat
trial
contain
hcw
may
underpow
detect
differ
arm
two
larger
trial
includ
review
publish
one
macintyr
et
al
involv
hcw
found
significantli
greater
protect
efficaci
continu
use
compar
continu
medic
mask
use
evid
select
use
superior
continu
medic
mask
use
prevent
clinic
respiratori
ill
limit
review
includ
restrict
english
languag
articl
use
search
scopu
databas
potenti
limit
identif
screen
process
carri
predominantli
one
author
sm
final
limit
number
studi
identifi
inclus
made
difficult
make
gener
conclus
costeffect
one
key
recommend
futur
econom
analys
attempt
appli
clinic
maskrespir
efficaci
data
prefer
clinic
trial
data
deem
applic
infecti
agent
intervent
set
rather
use
estim
deriv
expert
opinion
laboratori
test
studi
case
may
possibl
exampl
appropri
extrapol
clinic
trial
result
respiratori
virus
tuberculosi
ethic
reason
randomis
trial
data
collect
effect
respir
intervent
hcw
tuberculosi
prevent
use
type
efficaci
data
appli
studi
identifi
review
limit
result
studi
may
still
valid
howev
underli
assumpt
made
analys
need
care
consid
although
econom
evalu
conduct
use
maskrespir
strategi
hcw
tuberculosi
way
evalu
use
inform
polici
need
care
consid
costeffect
criteria
one
part
decis
make
process
intervent
may
specif
case
factor
given
less
weight
econom
evalu
would
less
relev
decis
maker
situat
set
respir
would
use
regardless
costeffect
may
use
evalu
situat
devic
current
recommend
given
set
futur
evalu
report
result
way
would
allow
easili
compar
nonpharmaceut
pharmaceut
intervent
eg
cost
per
qualityadjust
life
year
qali
gain
evalu
fail
report
result
appropri
format
limit
use
decis
make
mean
valu
maskrespir
intervent
compar
spend
healthcar
intervent
target
diseas
howev
case
use
intermedi
outcom
eg
case
prevent
still
use
compar
altern
way
reduc
specif
infect
event
may
provid
use
inform
decis
maker
futur
analyst
may
also
want
consid
whether
masksrespir
costeffect
use
hcw
season
influenza
context
costeffect
extrem
pandem
scenario
may
necessit
stockpil
suppli
masksrespir
although
cdc
recommend
hcw
use
mask
lowrisk
influenza
exposur
respir
highrisk
influenza
tuberculosi
exposur
current
lack
econom
evid
support
recommend
robust
econom
evalu
maskrespir
intervent
need
abbrevi
hcw
healthcar
worker
hepa
higheffici
particul
air
parp
power
air
purifi
respir
dm
dustmist
dmf
dustmistfum
compet
interest
rm
receiv
fund
influenza
vaccin
manufactur
gsk
csl
biotherapi
investigatordriven
research
also
advisori
board
wyeth
gsk
merck
author
contribut
atn
rm
initi
studi
atn
sm
develop
search
strategi
select
criteria
sm
carri
systemat
review
draft
initi
manuscript
atn
assist
interpret
econom
data
rm
assist
interpret
avail
efficaci
data
author
contribut
revis
manuscript
read
approv
final
manuscript
